4D Molecular Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of FDMT for the last quarter is 28.00 k USD, and it's 99.86% lower compared to the previous quarter. The net income of Q1 24 is -32.40 M USD.